PSNL Personalis, Inc.
Healthcare$9.04+0.00%OpenMarket Cap: $802.7M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
3.46
P/S
11.66
EV/EBITDA
-8.09
DCF Value
$1.13
FCF Yield
-11.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
13.7%
Operating Margin
-158.9%
Net Margin
-148.1%
ROE
-43.5%
ROA
-29.4%
ROIC
-35.8%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $15.5M | 1.8% | $-32.2M | $-30.0M | $— | — |
| Q4 null | $17.3M | 11.0% | $-25.3M | $-23.8M | $— | — |
| FY null | $0.00 | -Infinity% | $-88.1M | $-81.3M | $— | — |
| Q3 null | $14.5M | 13.2% | $-23.3M | $-21.7M | $— | — |
| Q2 null | $17.2M | 27.6% | $-21.8M | $-20.1M | $— | — |
| Q1 null | $20.6M | 35.0% | $-17.7M | $-15.8M | $— | — |
| Q4 null | $16.8M | 27.1% | $-18.1M | $-16.4M | $— | — |
| FY null | $84.6M | 31.7% | $-68.3M | $-81.3M | $— | — |
| Q3 null | $25.7M | 34.0% | $-14.4M | $-39.1M | $— | — |
| Q2 null | $22.6M | 35.6% | $-16.9M | $-12.8M | $— | — |
| Q1 null | $19.5M | 28.1% | $-18.9M | $-13.0M | $— | — |
| Q4 2023 | $19.7M | 26.5% | $-24.0M | $-26.6M | $-0.54 | — |